When adjusted for manufacturer discounts and rebates, as well as economic and population growth, medicine spending declined, on a per capita basis, by 2.2 percent in 2017. (Photo: Shutterstock)
Spending on drugs grew by 0.6 percent in 2017 after off-invoice discounts and rebates, according to IQVIA Institute's report, "Medicine Use and Spending in the U.S.: A Review of 2017 and Outlook to 2022."
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Katie Kuehner-Hebert
Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.
